Literature DB >> 31046072

Medication-Based Treatment to Address Opioid Use Disorder.

Alan I Leshner1, Victor J Dzau2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31046072     DOI： 10.1001/jama.2019.5523

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Geographic location of buprenorphine-waivered physicians and integration with health systems.

Authors:  Brendan Saloner; LeeKai Lin; Kosali Simon
Journal:  J Subst Abuse Treat       Date:  2020-05-12

2.  Offering Emergency Buprenorphine Without a Prescription.

Authors:  Payel Jhoom Roy; Michael D Stein
Journal:  JAMA       Date:  2019-07-08       Impact factor: 56.272

3.  Medicaid prevalence and opioid use disorder treatment access disparities.

Authors:  Michael R Richards; Ashley A Leech; Bradley D Stein; Melinda B Buntin; Stephen W Patrick
Journal:  Health Serv Res       Date:  2021-12-18       Impact factor: 3.402

4.  Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release.

Authors:  Ali Jalali; Philip J Jeng; Daniel Polsky; Sabrina Poole; Yi-Chien Ku; George E Woody; Sean M Murphy
Journal:  J Subst Abuse Treat       Date:  2022-07-02

5.  Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.

Authors:  Rosalyn Singleton; Sara Rutz; Gretchen Day; Melissa Hammes; Amy Swango Wilson; Mary Herrick; Connie Mazut; Laura Brunner; Jennifer Prince; Christine Desnoyers; Jennifer Shaw; Matthew Hirschfeld; Heather Palis; Amanda Slaunwhite
Journal:  J Addict Med       Date:  2022-03-01       Impact factor: 4.647

6.  Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.

Authors:  Amanda Sharp; Melissa Carlson; Veronica Howell; Kathleen Moore; Zev Schuman-Olivier
Journal:  J Subst Abuse Treat       Date:  2020-12-11

7.  Clarification of Reporting of Potential Conflicts of Interest.

Authors: 
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 8.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

Review 9.  Technologies for Opioid Use Disorder Management: Mobile App Search and Scoping Review.

Authors:  Farzan Sasangohar; Joseph Nuamah; Ranjana Mehta
Journal:  JMIR Mhealth Uhealth       Date:  2020-06-05       Impact factor: 4.773

10.  Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.

Authors:  Jesse L Yedinak; William C Goedel; Kimberly Paull; Rebecca Lebeau; Maxwell S Krieger; Cheyenne Thompson; Ashley L Buchanan; Tom Coderre; Rebecca Boss; Josiah D Rich; Brandon D L Marshall
Journal:  PLoS Med       Date:  2019-11-19       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.